Bonti Competitors and Similar CompaniesClear all
Bonti's competitors and similar companies include Polyplus-transfection, Mnemo Therapeutics and Muna Therapeutics.
 Bonti Bonti is a clinical stage biotechnology company developing a next generation neurotoxin for therapeutic and aesthetic indications. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  Muna Therapeutics Muna Therapeutics is a provider of transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases. | ||
Founding Date | Founding Date 2015 | Founding Date 2002 | Founding Date 2019 | Founding Date 2020 |
Type | Type Subsidiary | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Newport Beach, US HQ | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations HQ | Locations København, DK HQ |
Employees | Employees 5 | Employees 1133% increase | Employees 284% increase | Employees 55 |
Funding | ||||
Total funding raised | Total funding raised $ 36.1m | Total funding raised $ 3.2m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Polyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View company
Mnemo Therapeutics
HQ
Employees
28↑ 4% increase
Mnemo Therapeutics is a biotechnology company.
View companyMuna Therapeutics
HQ
København, DK
Muna Therapeutics is a provider of transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases.
View company